Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Phibro Animal Health (PAHC)

Phibro Animal Health amends credit agreement, revolver raised $125 million to $435 million

Neutral Impact 3 of 5 financing Written later

Phibro Animal Health entered into Amendment No. 1 to its credit agreement with Coöperatieve Rabobank U.A., New York Branch, on April 28, 2026. The amendment increases the revolving credit commitment by $125 million, from $310 million to $435 million, giving the company more borrowing capacity under its existing facility.

Key points

  • Revolving credit commitment rose by $125 million, from $310 million to $435 million
  • Amendment No. 1 is dated April 28, 2026, and amends the Original Credit Agreement dated July 3, 2024
  • Rabobank acts as administrative agent, collateral agent and L/C issuer

The filing

CompanyPhibro Animal Health (PAHC)
Form8-K, current report
Filed with the SECApr 30, 2026, 4:16 PM ET
Accession number0001104659-26-052956

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 30, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.